Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMIBrief Report Published on 2021-06-222022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] activate activated age antibodies antibody Antibody titre association baseline BMI BNT162b2 BNT162b2 vaccine body mass index changes in clinical trial correlation COVID-19 dose first dose Gender greater had no HCW healthcare worker immune response increase in Nasopharyngeal swab obesity of BNT162b2 Older Onset participant Participants priming SARS-CoV-2 SARS-CoV-2 antibody serum titer single dose titre Vaccine were assessed [DOI] 10.3390/vaccines9070685 PMC 바로가기 [Article Type] Brief Report
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity바이러스 유사 입자 백신에 cGAMP를 포함하면 면역원성이 향상됩니다.Article Published on 2021-06-182022-09-12 Journal: EMBO Reports [Category] MERS, SARS, 진단, [키워드] accompanied activate Administered Antibody titre antibody titres Antigen antigens CD4 CD8 T‐cell Cell cells cGAMP cyclic doses ENhance follicular Gag glycoprotein G Haemagglutinin immunology immunostimulatory Inclusion increase induce influenza A virus Methods & Resources mice Microbiology, Virology & Host Pathogen Interaction neutralising antibody Particle Particles platform produced Protein reduced responses SARS‐CoV‐2 spike SARS‐CoV‐2 titre type I interferon vaccination Vaccine vector vesicular stomatitis virus viral vaccine vector virus Virus neutralisation virus particle VLP VLPs [DOI] 10.15252/embr.202152447 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era의료 종사자의 SARS-CoV-2 감염: 백신 접종 전 시대의 베로나 SIEROEPID 연구 분석Article Published on 2021-06-142022-09-10 Journal: International Journal of Environmental Research an [Category] MERS, SARS, 진단, 치료기술, [키워드] 95% CI analyzed Antibody detection Antibody titre baseline Biobank Cohen’s kappa contribute COVID-19 dataset Demographic variables enrolled epidemiological Health health worker health workers hospital IgA IgG IgG and IgM IgM Immunological response increase in Italy Laboratory test Laboratory tests large sample longitudinal design management National number of infected risk Risk assessment SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection sensitivity serological test Serological tests Serosurvey Serum level specificity Spread spring statistically statistically significant Support Surveillance Swab Swab test swabs unit university university hospital vaccination Verona virus working [DOI] 10.3390/ijerph18126446 PMC 바로가기 [Article Type] Article
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial60세 이상의 건강한 성인을 대상으로 한 불활성화 SARS-CoV-2 백신(CoronaVac)의 안전성, 내약성 및 면역원성: 무작위, 이중 맹검, 위약 대조, 1/2상 임상 시험Randomized Controlled Trial Published on 2021-06-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] Adults Adverse reaction Adverse reactions age All participants Aluminium aluminium hydroxide antibody Antibody Response Antibody titre assigned baseline Beijing block Block randomisation China Chinese clinical trial CoronaVac COVID-19 COVID-19 vaccine Cutoff defined detectable development dose dose-escalation double-blind eight Endpoint enrolled groups healthy hydroxide immunogenicity inactivated injection injection site pain intervention group Intramuscular injection investigators Laboratory live SARS-CoV-2 Mild moderate morbidity morbidity and mortality Neutralising Antibodies neutralising antibody neutralising antibody titres occurred Older Older adults participant Participants Phase 1 Phase 2 phase 3 trial Placebo placebo group placebo-controlled positive primary immunogenicity Program random assignment randomised Randomly receive Registered reported research and development Safe Safety safety population SARS-CoV-2 SARS-CoV-2 vaccine Science second dose Serious Adverse Events Seroconversion seroconversion rate seronegative seropositive Seven severity technology the disease the placebo group titre Tolerability treatment allocation trial protocol vaccination Vaccine virus [DOI] 10.1016/S1473-3099(20)30987-7 PMC 바로가기 [Article Type] Randomized Controlled Trial
SARS-Cov-2 Natural Infection in a Symptomatic Cat: Diagnostic, Clinical and Medical Management in a One Health VisionArticle Published on 2021-06-012022-10-28 Journal: Animals : an Open Access Journal from MDPI [Category] COVID-19, [키워드] acute respiratory syndrome Analysis Antibody titre approach blood test bronchial pneumonia cat clinical clinical feature Clinical sign clinically condition Contact coronavirus COVID-19 COVID-19 diagnosis described description diagnostic disease ELISA ENhance ferret Human increase in infect inflammatory process knowledge management measure medical features and management Mild MOST natural natural infection Neutralizing antibodies one health oropharyngeal swab persistence plaque reduction neutralization positive presence of antibody reported responsible RT-qPCR RT-qPCR assay RT-qPCR molecular detection SARS-CoV-2 SARS-CoV-2 gene SARS-CoV-2 RNA serology simple susceptibility susceptible Swab symptomatic syndrome tested titre Treatment upper airways Viral genome sequencing viral mutation viral shedding virus vision [DOI] 10.3390/ani11061640 PMC 바로가기 [Article Type] Article
Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients회복기 SARS-CoV-2 환자에서 중화항체를 10개월 이상 유지Original Article Published on 2021-05-272022-09-01 Journal: Transboundary and emerging diseases [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] analysed Antibody titre approaches chemiluminescent immunoassay convalescent convalescent individual convalescent individuals data interpretation develop Evidence finding humoral immune response IgG antibodies immune responses Immunity immunofluorescence assay individual Infection investigated lack maintain maintenance Neutralization assay neutralization test Neutralizing antibodies neutralizing antibody Patient persistence positive correlation Primary infection Protective protective immunity SARS‐CoV‐2 SARS‐CoV‐2 Severity of infection specific antibodies [DOI] 10.1111/tbed.14130 PMC 바로가기 [Article Type] Original Article
Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain스페인의 6000명 이상의 의료 종사자에서 SARS-CoV-2 항체의 혈청 유병률Article Published on 2021-05-172022-09-12 Journal: International Journal of Epidemiology [Category] SARS, 진단, [키워드] 95% confidence interval acute respiratory syndrome Adding age age and sex Analysis antibody antibody screening Antibody testing Antibody titre Asymptomatic Barcelona carried Clinical data Cohort Contact coronavirus coronavirus disease COVID-19 COVID-19 incidence cross-sectional demonstrated determine Diagnosis disease Evidence exposure Factor female Final General population had no HCW Health care worker healthcare healthcare worker Healthcare workers high risk highest hospital IgG Immunoglobulin incidence Infection median Mild moderate moderate-severe Older Patient patients positive Region risk SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection seropositive Seroprevalence Spain Spanish subject utility [DOI] 10.1093/ije/dyaa277 PMC 바로가기 [Article Type] Article
Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccineResearch Article Published on 2021-05-112022-10-31 Journal: Diabetes/metabolism research and reviews [Category] COVID-19, SARS, [키워드] age antibody Antibody titre approach benefit blood sample BMI body composition booster Central obesity clinical collected COVID‐19 demographics determine elapsed enrolled Gender healthcare worker hypertension hypertensive immunogenicity independent Infection likelihood mRNA vaccine Multivariate analysis neutralizing antibody normotensive obesity parameter Pfizer/BioNTech Result SARS CoV‐2 SARS‐CoV‐2 separated serological response serum lipid Side effect smoker smoking subject titre titres vaccination Vaccine variable virus Waist circumference was performed were measured were recorded [DOI] 10.1002/dmrr.3465 PMC 바로가기 [Article Type] Research Article
Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers영국 주요 근로자의 자가 보고 징후 및 증상과 SARS-CoV-2 항체 검출 간의 연관성Article Published on 2021-05-012022-09-11 Journal: The Journal of Infection [Category] Fulltext, SARS, 진단, 치료기술, [키워드] antibodies Antibody titre antibody titres association belief collected compatible symptoms COVID-19 COVID-19 disease COVID-19 illness cross-sectional study Euroimmun fire healthcare worker illness immunoassay immunoassays in some individual Laboratory testing PCR positivity police positive PCR positive PCR result profile recruited reported rescue respiratory Respiratory illness Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody Screening sensitivity serology seronegative seropositive seropositive individuals Seropositivity Signs and symptoms stream Symptom symptom onset Symptoms symptoms of COVID-19 United Kingdom [DOI] 10.1016/j.jinf.2021.03.019 PMC 바로가기 [Article Type] Article
Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals유세포 분석에 의한 SARS-CoV-2 혈청 전환의 민감한 검출은 노출되지 않은 개인에서 핵단백질 반응성 항체의 존재를 나타냅니다Article Published on 2021-04-202022-09-10 Journal: Communications Biology [Category] MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] antibodies antibody Antibody titer Antibody titers Antibody titre Cohort collected Combination detect develop ELISA ELISAs flow cytometric flow cytometry gold gold standard IgG and IgM IgM antibodies immunoassay immunogenic individual individuals Laboratory nucleoprotein pandemic performed Protein RBD reactive reveal SARS-CoV-2 SARS-CoV-2 proteins sensitive Seroconversion serology Spike protein spike receptor-binding domain subunit the spike protein Viral Viral antigen viral antigens viral infection [DOI] 10.1038/s42003-021-02011-6 PMC 바로가기 [Article Type] Article